Model
Edge
PhaseBio Pharmaceuticals Inc
0001709415
Filing Type
4
Filing Date
5/19/2022
Updated
5/20/22, 10:45 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership